Literature DB >> 9249051

NMR investigations of the role of the sugar moiety in glycosylated recombinant human granulocyte-colony-stimulating factor.

V Gervais1, A Zerial, H Oschkinat.   

Abstract

Human granulocyte-colony-stimulating factor (G-CSF) is a hematopoietic growth factor that plays a major role in the stimulation of the proliferation and maturation of granulocyte neutrophil cells. With the recent increased understanding of its biological properties in vivo together with available preparations of recombinant human G-CSF, this growth factor has become an essential agent for clinical applications. The presence of an O-linked carbohydrate chain at position 133 greatly improves the physical stability of the protein. To clarify the molecular basis for the stabilisation effect of saccharide moieties on human G-CSF the whole glycoprotein expressed in CHO cells has been investigated by means of two 1H-NMR-spectroscopy and two 1H-detected-heteronuclear 1H-13C experiments at natural abundance, and compared with the non-glycosylated form. The present NMR study reports assignments of 1H and 13C resonances of the bound saccharidic chain NeuNAc(alpha2-3)Gal(beta1-3)[NeuNAc(alpha2-6)]GalNAc, where NeuNAc represents N-acetylneuraminic acid, and demonstrates the alpha-anomeric configuration of the N-acetylgalactosamine-threonine linkage. It also provides results suggesting that the carbohydrate moiety reduces the local mobility around the glycosylation site, which could be responsible for the stabilising effect observed on the glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249051     DOI: 10.1111/j.1432-1033.1997.00386.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Role of glycosylation in structure and stability of Erythrina corallodendron lectin (EcorL): a molecular dynamics study.

Authors:  Sandeep Kaushik; Debasisa Mohanty; Avadhesha Surolia
Journal:  Protein Sci       Date:  2011-03       Impact factor: 6.725

Review 2.  Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  Glycosylated analogs of formaecin I and drosocin exhibit differential pattern of antibacterial activity.

Authors:  Sariya Talat; Menithalakshmi Thiruvikraman; Saroj Kumari; Kanwal J Kaur
Journal:  Glycoconj J       Date:  2011-10-04       Impact factor: 2.916

4.  Backbone dynamics measurements on leukemia inhibitory factor, a rigid four-helical bundle cytokine.

Authors:  S Yao; D K Smith; M G Hinds; J G Zhang; N A Nicola; R S Norton
Journal:  Protein Sci       Date:  2000-04       Impact factor: 6.725

Review 5.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

Review 6.  Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?

Authors:  M Höglund
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

7.  Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant in H9c2 rat cardiomyocytes.

Authors:  Hee Kyoung Chung; Eun Mi Ko; Sung Woo Kim; Sung-June Byun; Hak-Jae Chung; Moosik Kwon; Hwi-Cheul Lee; Byoung-Chul Yang; Deug-Woo Han; Jin-Ki Park; Sung-Gu Hong; Won-Kyong Chang; Kyung-Woon Kim
Journal:  BMB Rep       Date:  2012-12       Impact factor: 4.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.